Join us on Friday 21st of July for our free event exploring technology, digital capabilities and the future of the NHS. All welcome - book your tickets at: https://t.co/VDvZIsfnxe
'The treatment pathways, from diagnosis to rehabilitation, are at best fragmented and, in too many areas of the country, absent.'
@IshmaelBeckford is among the signatories of a letter calling for more investment in neuro care in the Times: https://t.co/HpW6QUl3mQ
#RightToRehab
UK Physios - all specialities, please spare 15 minutes of your time to complete the short survey 👇👇👇 Your thoughts, and experiences will enrich the findings. Sharing with colleagues and Retweets are greatly appreciated 🌟
https://t.co/G4m8nG2yy6
#Physios#Fitnote
What a day hearing about the innovation partnerships work on #enhanced clinical practice #apprenticeship schema development @NHSE_WTE really enjoyed working with @mclarkson20 & @J_A_RadTutor over the last few months on this. Brilliant opportunities ahead for @SCoRMembers
Value physiotherapy staff.
The government must urgently address recruitment and retention of physiotherapy staff in the workforce plan, which will be published this week.
#RightToRehab
Physios from around the world 🌎working in practice, please share your views on beliefs, practices and barriers to engagement with research 📝👇👇 Click the link for further information. https://t.co/IMR8aJnnY7
📢 IFESS Careers
New FES Research neurophysio post in the UK!
Role split between FES clinics and working on new exciting multicentre EME NIHR clinical trial examining FES on Parkinson's disease.
further details👇
https://t.co/SAIv7yJn79
https://t.co/gh3uyul5Xp
@ACPIN_UK
R u a physio working in the UK, with people of a working age? We need your help! ⬇️⬇️⬇️⬇️
Please see this link or scan the QR code for further information:
https://t.co/G4m8nG2yy6
#physiotherapy#fitnote#fitnessforwork#workplacehealth#FCP
'This is devastating for patients'.
@KMiddletonCSP talks about the impact that the loss of rehab space is having on members and patients.
Our recent survey revealed the shocking impact of the problem.
#RightToRehab
We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!
This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.
Recruitment is not yet open for our clinical trial. We’ll announce more information on this soon!